指南与共识复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

德国-奥地利S3指南:心肌梗死并发心源性休克的诊断、监测与治疗

The German-Austrian S3 Guideline "Cardiogenic Shock Due to Myocardial Infarction: Diagnosis, Monitoring, and Treatment".
指南 / 共识 · Thorac Cardiovasc Surg · 2020-12-24
一句话结论心肌梗死并发心源性休克病死率仍近40%至50%,德国-奥地利八学会S3指南更新了早期血运重建、ICU治疗与机械循环支持等推荐。

尽管急性心肌梗死因早期血运重建使死亡率下降,心源性休克仍是其主要死因,死亡率仍接近40%至50%。心源性休克是多器官功能障碍综合征,常并发全身炎症反应综合征,后者对预后的影响超过心肌收缩功能下降。欧美心肌梗死指南仅聚焦介入或外科方面,因此德国和奥地利八个专业学会(包括德国胸心血管外科学会)于2010年发布S3指南,涵盖早期血运重建、血运重建技术、ICU治疗(包括通气、输血方案、辅助药物治疗和机械支持装置)。过去3年该指南因部分主要推荐过时或出现新证据而更新,本综述按更新版指南概述管理,重点是与心脏外科相关的循证推荐。

要点

  • 心源性休克仍是急性心肌梗死主要死因,死亡率仍接近40%至50%,早期血运重建带来的死亡率下降未能消除这一负担。
  • 心源性休克是多器官功能障碍综合征,常并发全身炎症反应综合征,后者对结局的影响超过心脏收缩功能降低本身。
  • 欧美心肌梗死指南仅聚焦介入或外科方面,本S3指南由德国和奥地利八个专业学会联合制定,覆盖诊断、监测与治疗。
  • 指南涵盖早期血运重建、血运重建技术、ICU治疗(通气、输血方案、辅助药物治疗)和机械支持装置等主题。
  • 过去3年指南因部分主要推荐过时或出现新证据而更新,本综述重点介绍与心脏外科相关的循证推荐。

适用人群与场景

  • 心肌梗死并发心源性休克的患者。

研究设计与关键结果

  • 制定机构:德国和奥地利八个专业学会,包括德国胸心血管外科学会(German Society for Thoracic and Cardiovascular Surgery)。
  • 制定方法:基于证据的S3指南,于2010年发布,并在过去3年内因部分主要推荐过时或出现新证据而更新。
  • 覆盖主题:早期血运重建、血运重建技术、ICU治疗(包括通气、输血方案、辅助药物治疗)和机械支持装置。

证据类型、等级与局限

  • 证据类型:指南(德国-奥地利S3指南)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

指南或共识出处

  • 德国-奥地利S3指南《心肌梗死并发心源性休克:诊断、监测与治疗》(The German-Austrian S3 Guideline "Cardiogenic Shock Due to Myocardial Infarction: Diagnosis, Monitoring, and Treatment"),由德国和奥地利八个专业学会制定,2010年发布,过去3年内更新。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Despite advances in the treatment of acute myocardial infarction with subsequent mortality reduction, which are mainly caused by the early timing of revascularization, cardiogenic shock still remains the leading cause of death with mortality rates still approaching 40 to 50%. Cardiogenic shock is characterized by a multiorgan dysfunction syndrome, often complicated by a systemic inflammatory response syndrome that affects the outcome more than the reduction of the cardiac contractile function. However, both European and American guidelines on myocardial infarction focus on interventional or surgical aspects only. Therefore, experts from eight German and Austrian specialty societies including the German Society for Thoracic and Cardiovascular Surgery published the German-Austrian S3 guideline "cardiogenic shock due to myocardial infarction: diagnosis, monitoring, and treatment" to provide evidence-based recommendations for the diagnosis and treatment of infarction-related cardiogenic shock in 2010 covering the topics of early revascularization, revascularization techniques, intensive care unit treatment including ventilation, transfusion regimens, adjunctive medical therapy, and mechanical support devices. Within the last 3 years, this guideline was updated as some major recommendations were outdated, or new evidence had been found. This review will therefore outline the management of patients with cardiogenic shock complicating acute myocardial infarction according to the updated guideline with a major focus on evidence-based recommendations which have been found relevant for cardiac surgery.

来源:Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

参考来源

  1. Pilarczyk K, Werdan K, Russ M, et al. The German-Austrian S3 Guideline "Cardiogenic Shock Due to Myocardial Infarction: Diagnosis, Monitoring, and Treatment". Thorac Cardiovasc Surg. 2020. PMID: 33368106. doi:10.1055/s-0040-1719155

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。